Latest Biomarker Stories
Dramatically improving opportunities for patients to find the right clinical trial MOUNTAIN VIEW, California, January 27, 2015 /PRNewswire/ -- U.S.-based cancer
After 15 years of research and development by Ancon Medical on revolutionary disease screening technology, the Minnesota-based company has developed a cutting-edge medical device that can detect
Caris Appoints Dr. John Marshall as Chairman of the Network IRVING, Texas, Jan.
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence in Elucidating Disease Biology and Identifying Potential Treatment Options
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence IRVING, Texas, Jan.
SAN DIEGO, Jan. 13, 2015 /PRNewswire/ -- Citing a study recently published online in the Journal of the American Society of Nephrology (JASN), Astute Medical, Inc.
AUSTIN, Texas, Jan. 13, 2015 /PRNewswire/ -- Vermillion, Inc.
CHARLOTTESVILLE, Va., Jan. 12, 2015 /PRNewswire/ -- HemoShear, a privately held discovery stage biotechnology company, announced today a multi-year platform collaboration with Pfizer Inc.
HILDEN, Germany, January 12, 2015 /PRNewswire/ -- - QIAGEN's circulating tumor DNA test is now CE-IVD marked to assess EGFR mutation status in
According to a new study in the Journal of Neurotrauma, researchers from the University of Pennsylvania have announced the development of a blood test that could provide a quantifiable way to measure the impact of concussions or the success of a treatment regimen.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
More Images (2 images) »